首页> 美国卫生研究院文献>Canadian Urological Association Journal >3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores
【2h】

3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores

机译:3.4 kb线粒体基因组缺失可作为组织病理学良性活检核心中前列腺癌的替代预测生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently, we described a 3.4-kb mitochondrial genome deletion having significance for identifying malignant and benign prostate tissues (p < 0.001). This biomarker was also present in normal appearing tissue, in close proximity to a tumour indicating a “field effect.” In the present study, we report 4 cases (3 malignant, 1 benign) which suggest that this field effect may occur before tumourigenesis; this effect may also identify the presence of a small tumour focus/foci, which are difficult to detect with single or multiple biopsy procedures.
机译:最近,我们描述了一个3.4kb的线粒体基因组缺失,对识别恶性和良性前列腺组织具有重要意义(p <0.001)。该生物标志物也存在于正常出现的组织中,紧邻肿瘤,表明“场效应”。在本研究中,我们报告了4例(恶性3例,良性1例),这表明这种场效应可能在肿瘤发生之前发生。这种作用还可以识别出小的肿瘤病灶/病灶的存在,而这些病灶/病灶很难通过单次或多次活检来检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号